✦ LIBER ✦

The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease

✍ Scribed by Cepeda, E J; Williams, F M; Ishimori, M L; Weisman, M H; Reveille, J D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequent conversion of tuberculosis scre

✍ Hatzara, C.; Hadziyannis, E.; Kandili, A.; Koutsianas, C.; Makris, A.; Georgiopo 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 207 KB

Decreased production of chemokines in pa

✍ S.A. Radema; H.M. van Dullemen; G.N.J. Tytgat; S.J.H. van Deventer 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 134 KB

The use of anti-tumour necrosis factor-α

✍ THONG, B. Y. H. ;VASOO, S. ;KOH, E. T. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

European guidelines for the use of anti-

✍ Wolfgang Kruis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 13 KB

Comparison of recommendations for the us

✍ van den Berg, R.; Stanislawska-Biernat, E.; van der Heijde, D. M. F. M. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 83 KB

Influence of variants of Fcg receptor II

✍ J Ramirez, J L Fernadez-Sueiro, R Lopez, C Montilla… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 160 KB